CLBS Caladrius Biosciences Inc

Caladrius Biosciences Inc is a biopharmaceutical company. The company through its subsidiary is developing cellular therapeutics to treat diseases.

$0.53
As of 07/01/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/01/2001
Outstanding shares:  60,518,478
Average volume:  134,373
Market cap:   $32,080,845
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.36
PS ratio:   0.00
Return on equity:   -26.70%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy